Skip to main content
Caplight Logo









PathoAI

PathoAI

Private
HangzhouHealthcare & Life Scienceshttps://pathoai.com/

Last Round

Series A

Aug 4, 2025

Total Funding Raised

$2.78M

Company Overview

PathoAI is a healthcare technology company that develops AI-powered products and digital solutions for pathology diagnostics and pharmaceutical research.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

digital pathologymedical AIpathology AIcomputational pathologyWSIwhole-slide imagingAI diagnosticscancer diagnosticsdigital pathology platformpathology softwareclinical workflow automationprecision medicinemedical imaging AIcomputer visionIVD software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PathoAI Comparables

Compare PathoAI with similar companies based on industry and business-model similarity.

PathoAI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Thorough Future
89%
Hangzhou DiPath Technology Co., Ltd.
87%
Qritive
86%

PathoAI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 4, 2025
AngelNov 1, 2024
AngelMay 25, 2023
AngelMay 24, 2023
Pre SeedMar 16, 2021

PathoAI Investors

Notable investors and investment history

PathoAI Filings

Explore SEC and related filing metadata, where available.

PathoAI filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PathoAI's valuation, stock price, and market status.

Is PathoAI (医策科技) a public or private company?

PathoAI (医策科技) is a private company.

What is the current stock price of PathoAI (医策科技)?

PathoAI (医策科技) is a private company with no public stock price. No recent secondary market data is available.

How much is PathoAI (医策科技) worth (valuation)?

Valuation information for PathoAI (医策科技) is not publicly available.

Can I buy PathoAI (医策科技) stock?

PathoAI (医策科技) shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PathoAI (医策科技)'s last funding round?

PathoAI (医策科技)'s most recent funding round was Series A on August 4, 2025.

Who are the main investors in PathoAI (医策科技)?

Key investors in PathoAI (医策科技) include Taikun Fund.

Will PathoAI (医策科技) IPO soon?

No public IPO plans have been announced for PathoAI (医策科技).

How can I track PathoAI (医策科技) secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PathoAI (医策科技)'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHangzhou
Year Founded2021
Last FundingAug 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?